Clinical and electrophysiologic characteristics of left septal atrial tachycardia  by Marrouche, Nassir F et al.
Clinical and Electrophysiologic
Characteristics of Left Septal Atrial Tachycardia
Nassir F. Marrouche, MD, Arne SippensGroenewegen, MD, Yanfei Yang, MD, Samer Dibs, MD, FACC,
Melvin M. Scheinman, MD, FACC
San Francisco, California
OBJECTIVES It was the purpose of this study to define the electrophysiologic (EP) identity of left septal
atrial tachycardia (AT).
BACKGROUND The clinical and EP characteristics of this particular type of arrhythmia have not been fully
described.
METHODS A total of 120 patients with AT underwent invasive EP evaluation. Five patients (two men
and three women; mean age 49  15 years) with left septal AT were identified. Mapping of
the right and left atrium was performed using conventional electrode catheters (five patients)
and a three-dimensional electroanatomic mapping system (three patients) followed by
radiofrequency (RF) ablation at the earliest site of local endocardial activation.
RESULTS Five tachycardias with a mean cycle length of 320  94 ms were mapped, and the earliest
endocardial electrogram occurred 22  10 ms before the onset of the surface P-wave. Three
left septal ATs were found to be originating from the left inferoposterior atrial septum and
two from the left midseptum. During tachycardia, positive (three patients), biphasic
negative-positive deflection (one patient), or isoelectric (one patient) P waves were recorded
in lead V1. The inferior leads demonstrated a positive or biphasic P-wave morphology in four
of five patients (80%). Four patients were given both adenosine and verapamil during AT. In
three of four patients, verapamil successfully terminated AT after adenosine had failed.
Adenosine successfully terminated AT in one of four patients. Successful RF ablation was
performed in all patients (mean 2.2  1.7 RF applications) without affecting atrioventricular
conduction properties. No recurrence of AT was observed after a mean follow-up of 14  8
months.
CONCLUSIONS Left septal AT ablation is safe and effective. There was no consistent P-wave morphology
associated with this particular type of AT. This arrhythmia appears to be resistant to
adenosine and moderately responsive to calcium antagonists. (J Am Coll Cardiol 2002;40:
1133–9) © 2002 by the American College of Cardiology Foundation
The clinical and electrophysiologic (EP) characteristics of
most supraventricular tachycardias (SVTs) have been well-
studied (1,2). Only 7% of all SVTs have been ascribed to
atrial tachycardia (AT), making this tachycardia the least
common form of SVT (1–3). The success rate of radiofre-
quency (RF) ablation for the treatment of AT ranges
between 60% and 95% depending on the arrhythmia mech-
anism, site of origin, and the mapping methods used to
localize the arrhythmia (3–7). The ability of adenosine to
terminate AT varies between 50% and 80% depending on
the AT site of origin (4–8). Recently, the EP identity of
right septal AT has been reported by Chen et al. (8). These
authors described a high sensitivity of right septal AT to
adenosine. Moreover, they showed a positive P-wave mor-
phology in lead V1 to be highly predictive of right postero-
septal AT. To our knowledge no study has yet defined the
clinical and EP characteristics of left septal AT. In this
study we report on the different electrocardiographic (ECG)
manifestations, location of arrhythmia origin, response to
adenosine and calcium antagonists, and the results of RF
ablation of left septal AT.
METHODS
Patients. Between March 1998 and February 2000, 120
patients with focal AT were evaluated in our laboratory.
Five of the 120 patients (4%) in whom mapping of both
atria revealed left septal AT were included in this study. The
study population consisted of two men and three women
with a mean age of 49  15 years (range, 35 to 76 years).
Atrial tachycardia was paroxysmal in four patients and
incessant in one. The mean duration of symptoms was 4.6
years (range, 2 to 10 years). Coronary artery disease and sick
sinus syndrome were present in one patient; one patient had
mild mitral valve regurgitation, while no structural heart
disease was present in the remaining three patients. All
patients had previously documented narrow QRS complex
tachycardia. All tachycardias were refractory to a mean of
2.6  1.6 antiarrhythmic drugs (range, 1 to 5). Three
patients failed treatment with beta-blockers while none
were treated with a calcium antagonist.
EP study protocol. Antiarrhythmic drugs were withheld at
least five half-lives before EP study. All patients gave
witnessed written informed consent. Electrode catheters
were positioned under biplane fluoroscopic guidance. Four
multipolar catheters were inserted percutaneously into the
right femoral vein. A 7F duodecapolar catheter (2-mm
interelectrode spacing; Daig Corporation, Minnetonka,
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Minnesota) was placed along the crista terminalis, and a 6F
octapolar catheter (2-mm interelectrode spacing; EP Tech-
nologies, Sunnyvale, California) was used to record His-
bundle potentials. A 6F quadripolar catheter (2-5-2-mm
interelectrode spacing; Daig Corporation) was placed at the
right ventricular apex. In two patients, a 7F quadripolar
asymmetrical thermocoupled ablation catheter (4-mm tip
electrode; EP Technologies) was used for atrial mapping
and ablation. In the other three patients, a nonthermo-
coupled 7F quadripolar catheter (Biosense Webster, Dia-
mond Bar, California) was used for the same purpose.
Coronary sinus (CS) recordings were performed using a 6F
decapolar catheter (2-5-2-mm interelectrode spacing; Daig
Corporation), which was inserted through the right internal
jugular vein.
The three-dimensional electroanatomic mapping system
used in this study has been described elsewhere (9,10). In
short, it consists of an electromagnetic location pad posi-
tioned under the patient’s back, a CARTO processor
(Biosense Webster), a Silicon Graphics workstation, and
two electromagnetic sensor-equipped catheters. One cath-
eter was used as a reference and was placed on the back of
the patient, while the second catheter was used as a rove for
identification of landmarks, mapping, and ablation.
The EP study included assessment of sinus node func-
tion, atrial and atrioventricular (AV) conduction properties.
Atrial overdrive pacing and right atrial extrastimuli were
used to induce AT. Atrial overdrive pacing was initiated at
a drive cycle length of 600 ms for 15 beats with decrements
of 20 to 250 ms unless tachycardia was initiated. Single,
double, and triple atrial extrastimuli were used if the above
mentioned protocol was not successful in inducing AT. If
both maneuvers failed to induce AT or if the AT was
nonsustained (i.e., lasting for 30 s with spontaneous
termination), intravenous isoproterenol was administered (1
to 6 g/min), and repeat pacing was performed to induce
the tachycardia. Atrial tachycardia was defined as a sudden
onset of rapid atrial rhythm with discrete P waves at rates
from 130 to 240 beats/min with a clearly defined isoelectric
baseline between P waves in all leads (11).
Two or more of the following criteria were used to
confirm the diagnosis of AT (12–17): 1) tachycardia initi-
ation independent of a critical atrial-His (A-H) interval; 2)
demonstration of AV conduction block during tachycardia;
3) if ventriculoatrial (VA) conduction was present, ability to
perform overdrive pacing via the right ventricle at a cycle
length 10 to 40 ms shorter than the cycle length of AT and
with the electrogram sequence immediately after the last
ventricular paced beat showing an “atrial-atrial-ventricular”
(A-A-V) pattern; 4) demonstration of AV dissociation with
ventricular pacing; 5) delivery of a single atrial-paced beat
during AT producing a variable VA interval of the return
cycle; and 6) delivery of a single ventricular-paced beat
during AT advancing the His-bundle potential without
affecting atrial activation.
RF catheter ablation. The right atrium was mapped after
confirming the diagnosis of AT using the above mentioned
criteria. Conventional activation mapping was performed in
two patients, and combined conventional and three-
dimensional electroanatomic mapping was carried out in the
remaining three patients. The earliest local endocardial
activation relative to the onset of the P-wave on the surface
ECG was targeted for ablation. Radiofrequency energy was
delivered using an EPT 1000 generator (EP Technologies)
that allowed continuous observation of changes in energy,
temperature, and impedance. Radiofrequency energy was
applied in a power range from 10 to 50 W or using a
power-titrated temperature approach (50°C). In case the
earliest atrial activation site was proven to be located at the
right atrial septum, and to precede the onset of surface
P-wave by 15 ms, left atrial mapping was performed
before right atrial RF delivery. When RF application led to
AT termination within 10 to 15 s, energy delivery was
resumed for a total of 60 s. If the RF ablation application
failed to terminate the tachycardia, mapping was resumed to
find an earlier site. Immediately and 30 to 40 min after
successful RF ablation, burst pacing and programmed atrial
stimulation with and without isoproterenol was conducted
in order to confirm that the arrhythmia was no longer
inducible. After ablation each patient was monitored on
telemetry for 24 h before discharge.
P-wave analysis. Atrial tachycardia P-wave analysis was
performed during the EP study. A 12-lead surface ECG
was recorded at a paper speed of 50 and 100 mm/s. If the
P-wave could not be visualized during tachycardia due to
QRST overlap of the preceding heart beat, single premature
ventricular-paced beats were introduced to allow for better
visualization of the P-wave. If this maneuver failed to isolate
the P-wave, adenosine was given, and P-wave visualization
was achieved if the AT did not terminate. The P-wave
morphology was visually evaluated and based on consensus
between two observers.
Administration of verapamil and adenosine. In order to
assess the sensitivity of the tachycardia to verapamil and
adenosine, both drugs were administered as an intravenous
bolus during sustained AT in four of five patients. Vera-
pamil was administered at a dosage between 5 and 10 mg
over 30 s. Adenosine was administered at a dosage of 6 mg,
Abbreviations and Acronyms
A-A-V  atrial-atrial-ventricular pattern
A-H  atrial-His interval
AT  atrial tachycardia
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12 mg, and 18 mg over 2 to 3 s. The minimal dose required
for termination was documented.
Data analysis. Multiple comparisons were made with anal-
ysis of variance. Data were expressed as mean  SD. A
value of p  0.05 was considered statistically significant; p
value was not corrected for multiple comparisons.
RESULTS
EP study. One of the five study patients presented with
spontaneous sustained AT. Atrial overdrive pacing at a cycle
length ranging between 200 and 300 ms initiated AT in two
patients. Triple atrial extrastimuli were needed to induce
AT in one patient, and intravenous isoproterenol at 2
g/min was given to induce AT in the remaining patient.
The mean AT cycle length was 320  94 ms (range, 240 to
465 ms) (Table 1).
Different P-wave configuration during tachycardia com-
pared with sinus rhythm was observed in all patients. In
Patient 1, tachycardia initiation was independent of a
critical A-H interval (criteria #1), and AV Wenckebach
block during tachycardia (criteria #2) supported the diag-
nosis of AT. Patient 2 also showed criteria #1 and had an
A-A-V pattern (criteria #3) after ventricular pacing during
tachycardia. In addition, delivery of a single atrial-paced
beat during AT produced a variable VA interval of the
return cycle during tachycardia (criteria #5). Patient 3 also
showed criteria #3 and had AV dissociation at multiple
ventricular-paced cycle lengths (criteria #4). Patient 4 had
criteria #1, #2, and #3. In Patient 5 we demonstrated, in
addition to criteria #2, that delivery of a single ventricular-
paced beat during AT advanced the His-bundle potential
without affecting atrial activation (criteria #6).
P-wave configuration. The P-wave duration during tachy-
cardia (82  25 ms; range, 56 to 109 ms) was shorter than
the P-wave duration during sinus rhythm (115  25 ms;
range, 90 to 134 ms) (p  0.05). The different observed
P-wave morphologies are shown in Table 2. In lead V1 a
positive P-wave (Fig. 1A) was found in three patients, while
isoelectric (Fig. 1B) or biphasic (Fig. 1C) P waves (negative-
positive) were present in two patients. The rest of the
precordial leads showed a positive P-wave in three patients
and an isoelectric P-wave in the remaining two patients. In
lead I the P-wave was positive in three patients, isoelectric
in one patient, and biphasic (positive-negative) in one
patient. Lead II showed a positive P-wave morphology in
three patients, an isoelectric P-wave in one patient, and a
biphasic P-wave (positive-negative) in one patient. In lead
III the P-wave morphology was positive in one patient,
negative in two patients, and biphasic (positive-negative) in
two patients. Lead aVL showed a positive P-wave in one
patient, an isoelectric P-wave in one patient, and a biphasic
P-wave (negative-positive) in the remaining three patients.
While a short P-wave duration suggested a left septal site,
there were no specific morphology characteristics associated
with a left septal AT. Figures 1 to 3 represent surface
12-lead ECG from three study patients.
Response to verapamil and adenosine. Verapamil was
successful in terminating AT in all three patients in whom
the drug was administered. In the same group of patients,
adenosine with a maximum applied bolus of 18 mg failed to
terminate the tachycardia. In one patient verapamil was not
given, but 6 mg of adenosine was successful in converting
the patient back to sinus rhythm. Neither verapamil nor
adenosine was applied in the remaining patient (Table 1).
AT localization and catheter ablation. Mapping of the
right atrium showed that the earliest endocardial activation
originated from the septum in all patients. In two patients
RF application at the earliest site of right septal activation
(20 ms and 25 ms before the onset of the surface P-wave)
failed to terminate the tachycardia. Hence, the left atrium
was mapped in these two patients, and the earliest site of
activation was found to be midseptal in one and inferopos-
teroseptal in another patient (10 and 15 ms before the onset
of surface P-wave, respectively). In the remaining three
patients, the left atrium was mapped before right atrial RF
delivery because the earliest site of endocardial activation
located at the right atrial septum was 15 ms before the
onset of surface P-wave. Mapping of the left atrium revealed



















1 35 F 34 — yes no 1, 2 IPS 465 Spontaneous 10
2 46 M 40 MVR yes no 1, 3, 5 IPS 270 AOD 30
3 44 M 36 SSS, CAD n/a n/a 3, 4 IPS 240 Isoproterenol 20
4 76 F 38 — yes no 1, 2, 3 MS 260 3 ES 15
5 45 F 32 — n/a yes 2, 6 MS 366 AOD 28
*See text for explanation of criteria.
AOD  atrial overdrive pacing; AT  atrial tachycardia; CAD  coronary artery disease; EEA  earliest endocardial activation; ES  extrastimulus; IPS  inferoposterior
septum; LA  left atrium; MS  midseptum; MVR  mitral valve repair; n/a  not applied; SHD  structural heart disease; SSS  sick sinus syndrome.
Table 2. Surface P-Wave Morphology During Tachycardia
Patient
Location
of AT V1 I II III aVL
1 IPS    / /
2 IPS  0 0  0
3 IPS 0 /   
4 MS /    /
5 MS   / / /
  positive;   negative; I  isoelectric; /  biphasic; AT  atrial
tachycardia; IPS  inferoposterior septum; MS  midseptum.
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Figure 1. (A) Shows a 12-lead electrocardiogram (ECG) for Patient #4 with tachycardia originating from the left midseptal area. The P-wave in the insert
is enlarged to show slightly positive P-wave in lead V1, slightly positive in I, biphasic in II, III, aVL, and aVF. (B) Shows a 12-lead ECG for Patient #3
with tachycardia originating from the left inferoposteroseptal area. The P-wave in the insert is enlarged to show isoelectric P waves in lead V1, positive waves
in I, II, III, and aVL. (C) Shows a 12-lead ECG for Patient #4 with tachycardia originating from the left midseptal area. The P-wave in the insert is
enlarged to show biphasic P waves across the precordium, slightly positive waves in I, II, aVF, and isoelectric P waves in the remainder.
the earliest site of activation to be midseptal in one patient
and inferoseptal in two patients. Radiofrequency energy was
delivered at the earliest site of left atrial activation in all
patients during left septal AT (Figs. 2 and 3). The time
interval between local left septal activation and the onset of
the surface P-wave was 20  8 ms (range, 10 to 30 ms). A
mean of 2.2  1.7 RF energy applications (range, 1 to 5)
was required to terminate left septal AT. In three patients
Figure 2. (A) Shown are simultaneous recordings from surface lead II, Rove catheter records from the left septum, His bundle recording, and distal coronary
sinus (CS)1,2 and proximal CS3,4 recordings. The earliest activation site in the left septum was 30 ms before the onset of the surface P-wave. (B) Application
of radiofrequency energy to the earliest left septal site during tachycardia results in acceleration before return of sinus rhythm.
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the tachycardia terminated after 2 to 3 s of a single RF
application. Electrophysiologic study after successful abla-
tion showed no significant changes in AV nodal properties.
No AT recurrence was observed after a mean follow-up
time of 14  8 months (range, 8 to 29 months).
DISCUSSION
Main finding. This is the first report to define the ECG
and EP characteristics of left septal AT. We found that the
P-wave duration during tachycardia was significantly
shorter than during sinus rhythm, and this phenomenon
was believed to be related to a rapid biatrial spread from a
focal septal origin of activation. In contrast, the morpho-
logic features of the P waves were quite variable, and no
characteristic pattern was discernible. The tachycardia was
associated with a relatively short interval between the
earliest endocardial activation and the onset of the surface
P-wave and was found to be verapamil-responsive and
adenosine-resistant for most of the patients tested.
Comparison with prior studies. Previous studies have
reported on catheter mapping and ablation of AT (4,6,7).
With atrial free wall sites of AT origin, the time from
earliest endocardial activation to onset of the P-wave has
been shown to vary between 20 to 60 ms (4,6–8). Chen et
al. (8) reported that the interval between the earliest
endocardial activation and the onset of the P-wave was 36
6 ms in a series of 27 patients with ATs originating from the
right and left free walls. We cannot explain the discrepancy
between studies. Of note was the relatively short P-wave
duration during tachycardia. We propose that activation
interval for our patients with left septal AT can be explained
by the fact that activation originating from a septal focus has
ready access to both the right and left atrium over the
previously reported intra-atrial connections such as Bach-
man’s bundle, the region of the fossa ovalis, and the CS
(18–20). Sun et al. (19) demonstrated discordance in
activation time between the right and left atrial septum in
dogs during pacing at the right and left atrial septum. They
showed that left septal activation was completed in a
significantly shorter period of time compared with right
septal activation. These data are in line with the present and
previously published results, where left septal ATs demon-
strated a shorter P-wave duration compared with the
P-wave in sinus rhythm.
We could not find a characteristic P-wave morphology
for patients with left septal AT. This finding is in contrast
with prior studies, showing good sensitivity and specificity
in the use of the 12-lead ECG in the separation of right and
left atrial foci (21,22). These reports, however, did not
include patients with left septal foci. In contrast with our
findings, Chen et al. (8) described characteristic P-wave
morphology findings for patients with right septal foci.
They reported a positive P-wave in lead V1 and a negative
P-wave in the inferior leads in right posteroseptal AT, a
biphasic P-wave in lead V1 and a negative P-wave in the
inferior leads in right midseptal AT, and a biphasic P-wave
in lead V1 and a positive P-wave in the inferior leads in right
anteroseptal AT. It is interesting to note that the P-wave
Figure 3. Left anterior oblique of three-dimensional anatomic map for Patient #1. The His bundle recording site (His) superior vena cava (SVC), inferior
vena cava (IVC), coronary sinus (CS), and pulmonary veins are noted. The biatrial map shows earliest left septal activation with passive spread to both left
and right atrium. LIPV  left inferior pulmonary vein; LUPV  left upper pulmonary vein; RUPV  right upper pulmonary vein.
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morphology of septal AT originating from the right or left
atrium would demonstrate such significant differences.
The response to pharmacologic agents may allow insight
into the arrhythmogenic mechanism of left septal AT. A
positive response to verapamil was observed in all patients in
whom the drug was administered. Patients who responded
to a relatively low dose of verapamil but not to the maximal
dosage of adenosine may have microreentry involving a
calcium-dependent portion of the circuit. In contrast, the
patient who responded to adenosine may have a triggered
mechanism as reported by Chen et al. (23). The small
number of patients preclude definitive statements about
arrhythmia mechanism. The proximity of the successful site
of ablation to the AV node together with the positive
response to verapamil raises the possibility that tachycardias
may have involved the AV node. The aggregate of evidence
in terms of both the EP findings and lack of response to
maximal doses of adenosine would strongly mitigate this
possibility.
Conclusions. This study demonstrated that mapping and
ablation of left septal AT using conventional and three-
dimensional electroanatomic catheter mapping is safe and
effective. No specific 12-lead ECG P-wave morphology
appears to be associated with left septal AT. Moreover,
verapamil possesses a relatively high success rate in termi-
nating left septal AT, while this tachycardia seems to be
resistant to adenosine. Due to the relatively high sensitivity
of left septal AT to verapamil, microreentry could be
hypothesized as the underlying mechanism of this tachycar-
dia.
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